[Severe acute respiratory syndrome (SARS)].
Identifieur interne : 005C13 ( Main/Exploration ); précédent : 005C12; suivant : 005C14[Severe acute respiratory syndrome (SARS)].
Auteurs : Galia RahavSource :
- Harefuah [ 0017-7768 ] ; 2003.
Descripteurs français
- KwdFr :
- Canada (épidémiologie), Chine (épidémiologie), Humains, Organisation mondiale de la santé, Syndrome respiratoire aigu sévère (diagnostic), Syndrome respiratoire aigu sévère (mortalité), Syndrome respiratoire aigu sévère (physiopathologie), Syndrome respiratoire aigu sévère (épidémiologie), Ventilation artificielle, Vietnam (épidémiologie), Virus du SRAS (isolement et purification), Virus du SRAS (pathogénicité).
- MESH :
- diagnostic : Syndrome respiratoire aigu sévère.
- isolement et purification : Virus du SRAS.
- mortalité : Syndrome respiratoire aigu sévère.
- pathogénicité : Virus du SRAS.
- physiopathologie : Syndrome respiratoire aigu sévère.
- épidémiologie : Canada, Chine, Syndrome respiratoire aigu sévère, Vietnam.
- Humains, Organisation mondiale de la santé, Ventilation artificielle.
- Wicri :
- geographic : Canada, République populaire de Chine.
English descriptors
- KwdEn :
- Canada (epidemiology), China (epidemiology), Humans, Respiration, Artificial, SARS Virus (isolation & purification), SARS Virus (pathogenicity), Severe Acute Respiratory Syndrome (diagnosis), Severe Acute Respiratory Syndrome (epidemiology), Severe Acute Respiratory Syndrome (mortality), Severe Acute Respiratory Syndrome (physiopathology), Vietnam (epidemiology), World Health Organization.
- MESH :
- geographic , epidemiology : Canada, China, Vietnam.
- diagnosis : Severe Acute Respiratory Syndrome.
- epidemiology : Severe Acute Respiratory Syndrome.
- isolation & purification : SARS Virus.
- mortality : Severe Acute Respiratory Syndrome.
- pathogenicity : SARS Virus.
- physiopathology : Severe Acute Respiratory Syndrome.
- Humans, Respiration, Artificial, World Health Organization.
Abstract
On November 2002, 305 cases of atypical pneumonia appeared in southern China. In February 2003, cases were reported in Hong Kong and from there the disease spread to many other countries, mainly, China, Hong Kong, Singapore, Vietnam and Toronto in Canada. The syndrome was defined as Severe Acute Respiratory Syndrome SARS), and a person is suspected of having SARS if he/she became ill after November 1 2002, has a fever exceeding 38 degrees C, has symptoms of a respiratory disease and was in a risk area or in close contact with a SARS patient within ten days prior the appearance of symptoms. The World Health Organization has received reports of 4,836 cases, of which 293 persons have died. Most were family members or medical staff treating the patient, persons who came into close and prolonged contact with the patient. The estimated incubation period is two days to one week. Symptoms of the disease include fever, shortness of breath and cough. Ten percent of patients afflicted with SARS require artificial breathing. The mortality rate is 6-7%. A novel coronavirus is associated with this outbreak, and the evidence indicates that this virus has an etiologic role in SARS. Infection is transmitted from person to person through direct or close contact with airborne droplets or personal objects of an infected person. Patients must be isolated and treated by contact and airborne isolation. Treatment consists of support care and artificial respiration when required. The use of anti-viral medications has not yet proven effective.
PubMed: 12803049
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003337
- to stream PubMed, to step Curation: 003337
- to stream PubMed, to step Checkpoint: 002E95
- to stream Ncbi, to step Merge: 000161
- to stream Ncbi, to step Curation: 000161
- to stream Ncbi, to step Checkpoint: 000161
- to stream Main, to step Merge: 006083
- to stream Main, to step Curation: 005C13
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Severe acute respiratory syndrome (SARS)].</title><author><name sortKey="Rahav, Galia" sort="Rahav, Galia" uniqKey="Rahav G" first="Galia" last="Rahav">Galia Rahav</name><affiliation><nlm:affiliation>Chaim Sheba Medical Center, Tel Hashomer.</nlm:affiliation><wicri:noCountry code="subField">Tel Hashomer</wicri:noCountry></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2003">2003</date><idno type="RBID">pubmed:12803049</idno><idno type="pmid">12803049</idno><idno type="wicri:Area/PubMed/Corpus">003337</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003337</idno><idno type="wicri:Area/PubMed/Curation">003337</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003337</idno><idno type="wicri:Area/PubMed/Checkpoint">002E95</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002E95</idno><idno type="wicri:Area/Ncbi/Merge">000161</idno><idno type="wicri:Area/Ncbi/Curation">000161</idno><idno type="wicri:Area/Ncbi/Checkpoint">000161</idno><idno type="wicri:doubleKey">0017-7768:2003:Rahav G:severe:acute:respiratory</idno><idno type="wicri:Area/Main/Merge">006083</idno><idno type="wicri:Area/Main/Curation">005C13</idno><idno type="wicri:Area/Main/Exploration">005C13</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Severe acute respiratory syndrome (SARS)].</title><author><name sortKey="Rahav, Galia" sort="Rahav, Galia" uniqKey="Rahav G" first="Galia" last="Rahav">Galia Rahav</name><affiliation><nlm:affiliation>Chaim Sheba Medical Center, Tel Hashomer.</nlm:affiliation><wicri:noCountry code="subField">Tel Hashomer</wicri:noCountry></affiliation></author></analytic><series><title level="j">Harefuah</title><idno type="ISSN">0017-7768</idno><imprint><date when="2003" type="published">2003</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Canada (epidemiology)</term><term>China (epidemiology)</term><term>Humans</term><term>Respiration, Artificial</term><term>SARS Virus (isolation & purification)</term><term>SARS Virus (pathogenicity)</term><term>Severe Acute Respiratory Syndrome (diagnosis)</term><term>Severe Acute Respiratory Syndrome (epidemiology)</term><term>Severe Acute Respiratory Syndrome (mortality)</term><term>Severe Acute Respiratory Syndrome (physiopathology)</term><term>Vietnam (epidemiology)</term><term>World Health Organization</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Canada (épidémiologie)</term><term>Chine (épidémiologie)</term><term>Humains</term><term>Organisation mondiale de la santé</term><term>Syndrome respiratoire aigu sévère (diagnostic)</term><term>Syndrome respiratoire aigu sévère (mortalité)</term><term>Syndrome respiratoire aigu sévère (physiopathologie)</term><term>Syndrome respiratoire aigu sévère (épidémiologie)</term><term>Ventilation artificielle</term><term>Vietnam (épidémiologie)</term><term>Virus du SRAS (isolement et purification)</term><term>Virus du SRAS (pathogénicité)</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Canada</term><term>China</term><term>Vietnam</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Canada</term><term>Chine</term><term>Syndrome respiratoire aigu sévère</term><term>Vietnam</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Respiration, Artificial</term><term>World Health Organization</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Humains</term><term>Organisation mondiale de la santé</term><term>Ventilation artificielle</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term><term>République populaire de Chine</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">On November 2002, 305 cases of atypical pneumonia appeared in southern China. In February 2003, cases were reported in Hong Kong and from there the disease spread to many other countries, mainly, China, Hong Kong, Singapore, Vietnam and Toronto in Canada. The syndrome was defined as Severe Acute Respiratory Syndrome SARS), and a person is suspected of having SARS if he/she became ill after November 1 2002, has a fever exceeding 38 degrees C, has symptoms of a respiratory disease and was in a risk area or in close contact with a SARS patient within ten days prior the appearance of symptoms. The World Health Organization has received reports of 4,836 cases, of which 293 persons have died. Most were family members or medical staff treating the patient, persons who came into close and prolonged contact with the patient. The estimated incubation period is two days to one week. Symptoms of the disease include fever, shortness of breath and cough. Ten percent of patients afflicted with SARS require artificial breathing. The mortality rate is 6-7%. A novel coronavirus is associated with this outbreak, and the evidence indicates that this virus has an etiologic role in SARS. Infection is transmitted from person to person through direct or close contact with airborne droplets or personal objects of an infected person. Patients must be isolated and treated by contact and airborne isolation. Treatment consists of support care and artificial respiration when required. The use of anti-viral medications has not yet proven effective.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Rahav, Galia" sort="Rahav, Galia" uniqKey="Rahav G" first="Galia" last="Rahav">Galia Rahav</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005C13 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005C13 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:12803049
|texte= [Severe acute respiratory syndrome (SARS)].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:12803049" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |